相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deferoxamine Treatment Prevents Post-Stroke Vasoregression and Neurovascular Unit Remodeling Leading to Improved Functional Outcomes in Type 2 Male Diabetic Rats: Role of Endothelial Ferroptosis
Yasir Abdul et al.
TRANSLATIONAL STROKE RESEARCH (2021)
Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke
Anil Gulati et al.
CNS DRUGS (2021)
Structure-activity relationship studies of phenothiazine derivatives as a new class of ferroptosis inhibitors together with the therapeutic effect in an ischemic stroke model
Wei Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Acute ischemic stroke & emergency mechanical thrombectomy: The effect of type of anesthesia on early outcome
Vinay Byrappa et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
Effects of dietary polyphenol supplementation on iron status and erythropoiesis: a systematic review and meta-analysis of randomized controlled trials
Teng Xu et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2021)
Ferroptosis and traumatic brain injury
Zhiwen Geng et al.
BRAIN RESEARCH BULLETIN (2021)
Mechanisms of Modulation of Ferroptosis and Its Role in Central Nervous System Diseases
Qingyun Tan et al.
FRONTIERS IN PHARMACOLOGY (2021)
Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats
Bin Lan et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2020)
LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53
Jingjing Lu et al.
LIFE SCIENCES (2020)
Ferroptosis and Brain Injury
Leslie Magtanong et al.
DEVELOPMENTAL NEUROSCIENCE (2019)
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
Magdy Selim et al.
LANCET NEUROLOGY (2019)
Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis
Nuria DeGregorio-Rocasolano et al.
FRONTIERS IN NEUROSCIENCE (2019)
Deferoxamine Alleviates Iron Overload and Brain Injury in a Rat Model of Brainstem Hemorrhage
Xi Guo et al.
WORLD NEUROSURGERY (2019)
Inhibition of neuronal ferroptosis in the acute phase of intracerebral hemorrhage shows long-term cerebroprotective effects
Bin Chen et al.
BRAIN RESEARCH BULLETIN (2019)
Iron-chelating agents attenuate NMDA-Induced neuronal injury via reduction of oxidative stress in the rat retina
Kenji Sakamoto et al.
EXPERIMENTAL EYE RESEARCH (2018)
Nanogel-DFO conjugates as a model to investigate pharmacokinetics, biodistribution, and iron chelation in vivo
Yan Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice
Isaac Garcia-Yebenes et al.
STROKE (2018)
High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines
Khuloud Bajbouj et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage
Nuria DeGregorio-Rocasolano et al.
REDOX BIOLOGY (2018)
N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice
Saravanan S. Karuppagounder et al.
ANNALS OF NEUROLOGY (2018)
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke
Q-z Tuo et al.
MOLECULAR PSYCHIATRY (2017)
Neuroprotective effect of deferoxamine on N-methyl-D-aspartate-induced excitotoxicity in RGC-5 cells
Ying Tian et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
Chelation in metal intoxication-Principles and paradigms
Jan Aaseth et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2015)
Efficacy of Deferoxamine in Animal Models of Intracerebral Hemorrhage: A Systematic Review and Stratified Meta-Analysis
Han-Jin Cui et al.
PLOS ONE (2015)
The Clinical Effect of Deferoxamine Mesylate on Edema after Intracerebral Hemorrhage
Yao Yu et al.
PLOS ONE (2015)
High Dose Deferoxamine in Intracerebral Hemorrhage (Hi-Def) Trial: Rationale, Design, and Methods
Sharon D. Yeatts et al.
NEUROCRITICAL CARE (2013)
Role of the NMDA receptor and iron on free radical production and brain damage following transient middle cerebral artery occlusion
Doo Soon Im et al.
BRAIN RESEARCH (2012)
Prophylactic neuroprotection against stroke: low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged neuroprotection independent of HIF-1 function
Yanxin Zhao et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Safety and Tolerability of Deferoxamine Mesylate in Patients With Acute Intracerebral Hemorrhage
Magdy Selim et al.
STROKE (2011)
Iron-Related Brain Damage in Patients With Intracerebral Hemorrhage
Natalia Perez de la Ossa et al.
STROKE (2010)
Effects of deferoxamine on brain injury after transient focal cerebral ischemia in rats with hyperglycemia
Yingqi Xing et al.
BRAIN RESEARCH (2009)
Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke
Leah R. Hanson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Association between serum ferritin level and perihematoma edema volume in patients with spontaneous intracerebral hemorrhage
Manu Mehdiratta et al.
STROKE (2008)
Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1α and erythropoietin
Yun-Xia Li et al.
Neuroscience Bulletin (2008)
Terephthalamide-containing ligands: fast removal of iron from transferrin
Rebecca J. Abergel et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2008)
Thrombolysis with alteplase for acute ischaemic stroke in the Safe implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Nils Wahlgren et al.
LANCET (2007)
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke
Monica Millan et al.
STROKE (2007)
Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat
T Freret et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Hemochromatosis and iron-overload screening in a racially diverse population
PC Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage
T Nakamura et al.
JOURNAL OF NEUROSURGERY (2004)
Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke
SH Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Iron and iron-handling proteins in the brain after intracerebral hemorrhage
JM Wu et al.
STROKE (2003)
Body iron stores and early neurologic deterioration in acute cerebral infarction
A Dávalos et al.
NEUROLOGY (2000)
分享论文
